Skip to main navigation Skip to search Skip to main content

A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors

  • Ann W. Silk
  • , Biren Saraiya
  • , Roman Groisberg
  • , Nancy Chan
  • , Kristen Spencer
  • , Eugenia Girda
  • , Weichung Shih
  • , Marisa Palmeri
  • , Tracie Saunders
  • , Robert M. Berman
  • , Vlad Coric
  • , Suzie Chen
  • , Andrew Zloza
  • , Joshua Vieth
  • , Janice M. Mehnert
  • , Jyoti Malhotra

Research output: Contribution to journal › Article › peer-review

16   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science